Recently, human CES2 and murine Ces2c have been discovered as metabolic lipases showing reduced mRNA expression in the liver of NASH patients and in obese mouse models exhibiting NAFLD [7,8,27,28]. This evidence concerns the gene CES2 and metabolic dysfunction-associated steatohepatitis.